PeptimeBPC-157
Ordered BPC-157 from Peptime? Mail in a sample (US only) and let us test it for free.
Test my supplyPeptime's BPC-157 evidence is mixed: March batch BE94D tests missed purity at 98.8-98.9%, while June public tests improved to 99.6-99.8%. All results are from that batch, and one June vial was +18% overfilled.
Aged-domain history, a newly formed Delaware trail, and Australian registration/review signals complicate Peptime’s American legacy story. The report maps the Superpower-adjacent launch network, affiliate rails, and verification gaps without treating promotion as ownership proof.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Peptime rows.
Cancel anytime
About Peptime test results from Finnrick
Peptime is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 3 peptides and 11 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Peptime peptides in this dataset are BPC-157 (4 tests), GHK-Cu (1 test) and Retatrutide (6 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 11 recent tests.
Ordered BPC-157 from Peptime? Mail in a sample (US only) and let us test it for free.
Test my supply